Abstract-ATP-sensitive K ϩ channels (K ATP ) contribute to the regulation of tone in vascular smooth muscle cells. We determined the effects of protein kinase C (PKC) activation on the nucleoside diphosphate-activated (K NDP ) subtype of vascular smooth muscle K ATP channel. Phorbol 12,13-dibutyrate (PdBu) and angiotensin II inhibited K NDP activity of C-A patches of rabbit portal vein (PV) myocytes, but an inactive phorbol ester was without effect, and pretreatment with PKC inhibitor prevented the actions of PdBu. Constitutively active PKC inhibited K NDP in I-O patches but was without effect in the presence of a specific peptide inhibitor of PKC. PdBu increased the duration of a long-lived interburst closed state but was without effect on burst duration or intraburst kinetics. , activation of myosin light chain kinase, and contractile filament interaction. Vasoactive agonists, which produce dilation or constriction of resistance vessels, influence vascular smooth muscle tone in part by affecting the activity of K ϩ channels. 1 However, our understanding of the specific signaltransduction pathways involved, the identities of the K ϩ channels affected, and the circumstances under which different K ϩ channels contribute to the control of arterial diameter by vasoactive agonists is incomplete. 2 Several vasoconstrictors affect K ϩ channel activity in vascular myocytes. For example, voltage-clamp studies provide evidence for the regulation of delayed rectifier, 3-6 Ca 2ϩ -activated, 7,8 and K ATP 9 currents. Signal-transduction pathways involving the activation of protein kinase C (PKC) were implicated in the response to vasoconstrictors through the use of selective activators and inhibitors of PKC 3, 4, 6, 9 ; inhibition of delayed rectifier K ϩ current by angiotensin II or endothelin-1 was mimicked by diacylglycerol analogs or phorbol esters and prevented by PKC inhibitors. 3,4,6 K ATP currents of arterial myocytes are similarly affected by agonists and pharmacological manipulations that modulate PKC. 1,9 However, the identity of the vascular smooth muscle K ATP channel(s) regulated by PKC is unknown.
A TP-sensitive K ϩ channels (K ATP ), acting in concert with at least 3 other K ϩ channels, including delayed rectifier, large-conductance Ca 2ϩ -activated, and inward rectifier K ϩ channels, play an important role in the control of membrane potential and tone in vascular smooth muscle. 1 Variations in membrane potential are critical for regulating the influx of Ca 2ϩ via L-type Ca 2ϩ channels and thereby controlling the level of intracellular free Ca 2ϩ , activation of myosin light chain kinase, and contractile filament interaction. Vasoactive agonists, which produce dilation or constriction of resistance vessels, influence vascular smooth muscle tone in part by affecting the activity of K ϩ channels. 1 However, our understanding of the specific signaltransduction pathways involved, the identities of the K ϩ channels affected, and the circumstances under which different K ϩ channels contribute to the control of arterial diameter by vasoactive agonists is incomplete. 2 Several vasoconstrictors affect K ϩ channel activity in vascular myocytes. For example, voltage-clamp studies provide evidence for the regulation of delayed rectifier, [3] [4] [5] [6] Ca 2ϩ -activated, 7, 8 and K ATP 9 currents. Signal-transduction pathways involving the activation of protein kinase C (PKC) were implicated in the response to vasoconstrictors through the use of selective activators and inhibitors of PKC 3, 4, 6, 9 ; inhibition of delayed rectifier K ϩ current by angiotensin II or endothelin-1 was mimicked by diacylglycerol analogs or phorbol esters and prevented by PKC inhibitors. 3, 4, 6 K ATP currents of arterial myocytes are similarly affected by agonists and pharmacological manipulations that modulate PKC. 1, 9 However, the identity of the vascular smooth muscle K ATP channel(s) regulated by PKC is unknown.
In contrast to K ATP channels of cardiac myocytes (80 pS), 10 the channels of vascular myocytes possess a range of unitary conductance from 5 to Ͼ100 pS. 9 The reasons for this variability are obscure, but a strong case has been made, by Beech et al, 11, 12 and Zhang and Bolton, 13, 14 for the expression of multiple K ATP subtypes. The following 2 K ATP channels were identified in rat portal vein (PV; asymmetrical KCl conditions): (1) a 22-pS channel that was inactive in the absence of MgATP, but activated by nucleoside diphosphates (the K NDP subtype), and (2) a 50-pS cardiac-like K ATP channel referred to as the large conductance or LK subtype. 14 We tested the hypothesis that the K NDP subtype is the vascular K ATP channel modulated by PKC using C-A and I-O patches of freshly dispersed rabbit and rat PV myocytes. PKC activity of intact myocytes was modulated by exposure to angiotensin II or to phorbol ester in the absence or presence of selective PKC inhibitors. I-O patches were exposed to a constitutively active proteolytic fragment of PKC, and the effect on K NDP activity was determined. Our results provide the first evidence for a modulation by PKC of the K NDP subtype, but not the LK channel of vascular smooth muscle.
Materials and Methods
Rabbit and rat myocytes were isolated 15 and studied by C-A and I-O patch clamp 16 at 20°C to 22°C. Pipette and bath solutions, respectively, contained (in mmol/L) KCl 140, CaCl 2 1, MgCl 2 1, glucose 5.5, HEPES 10, and iberiotoxin 0.0002 and KCl 140, MgCl 2 2.3, glucose 10, EGTA 1, and HEPES 10 (pH 7.4 with KOH). For I-O patches, the bath had MgATP (0, 0.1, or 1 mmol/L) and MgADP (0 or 0.5 mmol/L). PdBu (50 nmol/L), 4␣-phorbol-12,13-didecanoate (PdDe) (50 nmol/L), chelerythrine (1 mol/L), 2,4-dinitrophenol (DNP) (50 mol/L), 2-deoxy-D-glucose (2-DG) (10 mmol/L), and glibenclamide (3 mol/L) were obtained from Sigma. Pinacidil, calphostin C (1 mol/L), and iberiotoxin were purchased from Calbiochem-Novabiochem Corp. Constitutively active PKC (PKM; 20 nmol/L) 17 and PKC (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) 18 (5 mol/L) were prepared as previously described. Paired Student t test and ANOVA followed by Bonferroni post hoc test were used for single and multiple comparisons, respectively. A level of PϽ0.05 was statistically significant.
An expanded Materials and Methods section is available online at http://www.circresaha.org.
Results

Identification of K NDP Channels
Initial experiments identified the K ATP channels of rabbit PV myocytes as the K NDP subtype. [11] [12] [13] [14] Figure 1 shows K NDP induced by pinacidil and blocked by glibenclamide, as well as a unitary current-voltage (I-V) relation. Similar results were obtained in 2 other patches, and the average changes in the product of the number of channels (N) and mean open probability (P O ) (NP O ) are given in Table 1 online (available at http://www.circresaha.org). K NDP activity was characterized by bursts of transitions separated by relatively long-duration, interburst intervals. Pinacidil-induced K NDP activity was apparent in 75% of C-A patches and was stable for Ͼ15 minutes; no change in NP O occurred in 15 to 30 minutes (0.619Ϯ0.187 versus 0.426Ϯ0.144 at 2 to 5 minutes; nϭ5; PϾ0.05). With 140 mmol/L KCl in the pipette solution, the unitary currents of C-A patches had a slope conductance of 41Ϯ0.9 pS (nϭ10) (Figure 1 ), but a slightly lower value of 37.3Ϯ1.5 pS (nϭ7) was obtained for I-O patches (symmetrical 140/140 mmol/L transmembrane KCl gradient). In contrast to cardiac K ATP and vascular LK channels, K NDP channels require intracellular MgATP for activity. 14 Figure 1 shows that patch excision into MgATP-free solution failed to activate the 40-pS channels, and when K NDP channels were activated with pinacidil in the C-A configuration, excision caused a loss of activity. Similar results were obtained from 3 and 5 additional patches, respectively. These properties are consistent with those reported previously. 14 
Inhibition of K NDP by Phorbol Ester or Angiotensin II
To assess the effect of PKC on K NDP , myocytes were treated with PdBu in the presence of pinacidil (Figure 2 ). PdBu caused K NDP activity to decline, and NP O values for K NDP in PdBu and pinacidil were significantly lower than pinacidil alone (Table 1 online; available at http://www.circresaha.org). Additionally, exposure to PdBu of 3 myocytes exhibiting background K NDP activity also caused a decline in activity, and, in 3 patches exposed to pinacidil and PdBu and held for a sufficiently long period to permit washout of PdBu, complete reversibility of the decline in activity was observed (data not shown).
Angiotensin II is known to activate PKC in smooth muscle cells, 19 to inhibit delayed rectifier K ϩ channels, 4 and to cause a decrease in K ATP current of mesenteric arterial myocytes via PKC. 20 In the presence of angiotensin II, pinacidil-induced K NDP activity of C-A patches of rabbit PV myocytes was inhibited ( Figure 3) ; on average in 4 patches, application of angiotensin II caused a decline in NP O of Ͼ10-fold (Table 1 online; available at http://www.circresaha.org).
Effect of Inactive Phorbol Ester and PKC Inhibitors
To control for possible non-PKC-dependent effects of PdBu, 2 different approaches were used, as follows: myocytes were (1) exposed to the inactive phorbol ester PdDe or (2) pretreated with a PKC inhibitor, chelerythrine or calphostin C, before treatment with PdBu ( Figure 4 ). PdDe failed to affect K NDP activity after more than 20 minutes of treatment ( Figure 4 ). In PdBu, NP O declined within 10 minutes in all patches, but no change in activity was observed in PdDe within at least 12 minutes of recording. Figure 4C shows a representative example of the effect of pretreatment with calphostin C for 10 to 15 minutes on K NDP activity. No effect on background or pinacidil-induced activity was noted, and subsequent exposure to PdBu did not alter K NDP activity. A similar lack of effect of PdBu was observed after pretreatment with chelerythrine. See Table 1 To determine the effect of PKC on burst kinetics, Ͼ100 bursts were analyzed in each condition from 3 patches. The Table  shows that burst duration and interburst interval were longer and shorter, respectively, in pinacidil compared with background K NDP activity. In both cases, however, PKC activation caused a significant increase in interburst interval, but burst duration was unaffected (Table) .
Effect of PKC Activation on K NDP Channel Kinetics
Effect of PKC Activation on
Effect of Constitutively Active PKC
To directly assess the effect of PKC on K NDP , patches were excised into bath solutions containing MgATP (0.1 or 1 mmol/ L). In contrast to the absence of K NDP activity in MgATP-free solution (Figure 1 ), patches excised into solutions containing 1 mmol/L MgATP displayed robust activity, which was stable for Ͼ20 minutes without rundown (data not shown) and further enhanced by exposure to 0.1 mmol/L MgATP ( Figure 5A ). Figure 5 shows that PKM in the presence of the specific peptide inhibitor, PKC (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) , failed to affect channel activity, but NP O was decreased by PKM alone. Similar results with PKM and PKC (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) were obtained for 3 additional I-O patches: on average, PKM caused a 63% decline in NP O to 0.857Ϯ0.041 from 2.678Ϯ0.047 in 0.1 mmol/L MgATP (PϽ0.05). Reversibility was observed in 2 of 3 patches (eg, Figure 5D ).
NP O of cardiac K ATP channels was found to increase with PKM treatment in the presence of 1 mmol/L compared with a decrease in 0.05 mmol/L MgATP. 21 For this reason, we also treated 6 I-O patches with PKM in the presence of 1 mmol/L MgATP and 0.5 mmol/L MgADP. Figure 5B shows that PKM inhibited the channels in the presence of 1.0 mmol/L MgATP; in 6 patches, NP O was 0.296Ϯ0.087 in ATP/ADP alone and application of PKM and PKC(19-31) was without effect (NP O ϭ0.295Ϯ0.016), but PKM alone decreased NP O to 0.091Ϯ0.047 (PϽ0.05). The effect of PKM was fully reversed in 3 of 6 patches during washout (respective NP O s of 0.426Ϯ0.134 before, 0.137Ϯ0.089 during, and 0.449Ϯ0.131 after PKM for these myocytes). Variability in reversibility on washout of PKM may be due to loss or inactivation of phosphatase activity after patch excision.
Effect of PKC on K ATP of Rat PV
We determined whether the 2 K ATP channels of rat PV were similarly modulated by PKC. K NDP activity was seen in preliminary experiments using pinacidil, but LK channels were not activated (data not shown), as reported previously. 14 For this reason, the metabolic inhibitors DNP and 2-DG were used. Figure 6A shows a representative C-A patch recording in which both subtypes of 40-pS (38.5Ϯ2.7; nϭ4 patches) and 70-pS (70.5Ϯ1.7; nϭ3 patches) conductance, glibenclamide-sensitive channels were identified. Similar results were obtained in 3 additional patches. Treatment with PdBu in the presence of metabolic inhibitors reduced K NDP NP O from 0.200Ϯ0.061 to 0.035Ϯ0.019 (PϽ0.05) in 4 patches. However, as shown in Figure 6B , the 70-pS channels were unaffected by PdBu. Similar results were obtained in 2 additional patches containing only the 70-pS channel and in 3 patches in which both subtypes were present. NP O values were 0.077Ϯ0.027 and 0.094Ϯ0.036 (PϾ0.05) in the absence and presence of PdBu, respectively, for the patches containing only the LK subtype. In patches contain- ing both subtypes, only the K NDP channels were inhibited by PdBu (data not shown).
Discussion
This study identifies the regulation by PKC of a 40-pSconductance K NDP subtype, but not a larger-conductance, 70-pS K ATP channel of vascular smooth muscle cells. The properties of the 40-and 70-pS channels studied here are consistent with those previously described. [11] [12] [13] [14] Suppression of K NDP channel activity by PKC activation was due to an increased time spent in a long-lived interburst closed state, was mimicked by treatment with angiotensin II, and was completely blocked by pretreatment with the PKC inhibitor calphostin C or chelerythrine. The decline in K NDP channel activity due to PKC activation identified in this study may account for the previously reported reduction in whole-cell K ATP currents after treatment of vascular myocytes with vasoconstrictors, phorbol esters, or diacylglycerol analogs, 1 and therefore, for the contribution of this conductance to the regulation of vascular smooth muscle tone via intracellular signaling cascades involving PKC.
K ATP currents have been identified in a variety of vascular myocytes, and K ϩ channel-opening drugs induce a voltageindependent K ϩ current that is suppressed by glibenclamide or reductions in intracellular MgATP. 9 However, the identity of the single channels involved is controversial: the variability in unitary conductance (5 to Ͼ100 pS 9 ) prompted the suggestion that multiple subtypes may be expressed, but molecular biological evidence confirming the identity of the presumed K ATP channels is lacking. Rat PV myocytes contain 2 glibenclamide-sensitive channels with distinct unitary conductance and sensitivities to K ϩ channel opening drugs, intracellular MgATP, and nucleoside diphosphates. 11-14 LK channels were (1) relatively insensitive to pinacidil and glibenclamide and (2) activated in I-O patches in MgATP-free solution. 14 In contrast, K NDP channels were (1) activated by pinacidil at low concentrations; (2) inactive in the absence of intracellular MgATP; and (3) activated by nucleoside diphosphates, the latter prompting their classification as K NDP channels. [11] [12] [13] [14] 22 Similar channels have been observed in myocytes of several vascular and nonvascular smooth muscles. [11] [12] [13] [14] [22] [23] [24] [25] [26] The properties exhibited by the channels of rabbit and rat PVs studied here are consistent with these previous reports. However, our results are the first to indicate that these subtypes also differ with respect to their modulation by PKC.
Two different approaches were taken to assess the modulation by PKC, as follows: (1) the activity of PKC of intact myocytes was manipulated pharmacologically, and (2) a constitutively active PKC, PKM, was used. PdBu and angiotensin II were used to activate PKC and were found to reduce K NDP channel activity. The possibility that nonspecific effects of phorbol ester treatment were involved was ruled out using an inactive phorbol ester, PdDe. Additionally, pretreatment with inhibitors of PKC, calphostin C or chelerythrine, having distinct structures and mechanisms of action, 27, 28 prevented the PdBu-induced inhibition of K NDP channel function. These data suggest that activation of PKC via ligand binding to a receptor or direct activation by a phorbol ester leads to a decline in K NDP channel activity in intact vascular myocytes.
Direct evidence for modulation of K NDP activity by PKC was obtained; PKM suppressed the activity of K NDP in I-O patches, and this inhibition was blocked by the specific inhibitor peptide of PKC (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) . A similar inhibition of K NDP channel activity during exposure to PKM was observed with 0.1 and 1.0 mmol/L MgATP in the bath solution. This result is different from that previously reported for cardiac K ATP channels, in which inhibition by PKM was observed at 0.05 mmol/L, but an increase in activity occurred at 1.0 mmol/L. 18, 21 Thus, the inhibition of vascular K NDP activity by PKC at physiological levels of intracellular ATP occurred via a mechanism distinct from that shown for the regulation of cardiac K ATP channels.
We determined the mechanism accounting for the change in NP O using membrane patches containing single K NDP channels. K NDP channel activity exhibited bursts of transitions between the open and closed states separated by extended intervals in a long-lived closed state. The mean intraburst open and closed times were not affected by pinacidil, but burst duration and interburst intervals were longer and shorter, respectively, consistent with the previously reported modulation of K ATP gating by K ϩ channel openers. 9 Activation of PKC did not affect intraburst kinetics or burst duration, but interburst interval was significantly increased. This change provides a possible explanation for the effects of PKC-mediated phosphorylation on gating. The long-lived interburst interval is thought to reflect a transition from the open state into a closed state(s) in which ATP is bound to the channel. 29 PKC-mediated phosphorylation may stabilize the channels in this interburst closed state by altering ATP binding and decreasing its dissociation. Interestingly, stimulation of cardiac K ATP activity by PKC is due to a change in the stoichiometry of ATP binding, 18, 21 but this alteration is associated with an increase in burst duration (P. Light, unpublished data, 1999).
The exclusive presence of K NDP channels in rabbit PV, 12,22 rat mesenteric artery, 13 and guinea pig coronary artery 30, 31 suggests that their modulation can be exclusively responsible for the decline in whole-cell K ATP currents by vasoconstrictors, diacylglycerol analogs, or phorbol esters via PKC. 1, 20 However, the presence of additional glibenclamide-sensitive K ATP subtypes raises the possibility that multiple channels may be involved in some vessels. It is unlikely, however, that an inhibition of the LK subtype is involved. We base this view on the lack of effect of PKC activation on the 70-pS subtype, but marked inhibition of the 40-pS K NDP channels of rat PV myocytes. The lack of inhibition of the 70-pS LK channels by PdBu indicates that despite sharing properties with cardiac K ATP subtype, 14 such as conductance and relative insensitivity to pinacidil, they are not identical in terms of their modulation by PKC. Yamada et al 32 and Satoh et al 33 demonstrated that recombinant K ATP consisting of Kir6.1 and SUR2B proteins share biophysical and pharmacological properties with K NDP channels. [11] [12] [13] [14] In contrast, cardiac K ATP channels are thought to consist of Kir6.2 and SUR2A subunits. 9 Thus, a difference in subunit composition likely accounts for the divergent effects of PKC on vascular K NDP and cardiac K ATP activity. Moreover, the lack of effect of PKC on LK channels of rat PV indicates that they likely possess a subunit composition distinct from that of K NDP and cardiac K ATP .
We favor the view that the K NDP channels are directly regulated by PKC-dependent phosphorylation of the Kir6.x or SUR subunit(s). The ability of PKM to cause a rapid inhibition of channel activity in I-O membrane patches in this study is consistent with this interpretation. However, angiotensin II also activates signaling cascades involving mitogen-activated protein kinase and tyrosine kinase, and inhibitors of tyrosine kinase activity were previously found to block the reduction in esophageal smooth muscle K ATP current by M 3 receptor activation or phorbol esters. 34 Angiotensin II inhibited arterial K ATP currents via PKC, 20 but whether tyrosine kinase also regulates vascular K NDP remains to be determined. Further characterization of the signaling pathways for regulation of K NDP , identification of the PKC isoform(s) involved, and determination of the molecular mechanism(s) involved will require the use of purified PKC isoenzymes, isoform-specific antibodies, and identification of the specific phosphorylation sites within the K NDP channels.
In summary, these results provide the first evidence that a decline in K NDP channel activity may contribute to the previously reported inhibition of whole-cell K ATP currents by activators of PKC. [35] [36] [37] Reduction in the open probability of the K NDP subtype of vascular K ATP channel due to an increased occupancy of a long-duration interburst closed state may contribute to depolarization, Ca 2ϩ channel activation, and increased vascular smooth muscle tone in response to vasoconstrictors that activate PKC.
